Reprogramming to developmental plasticity in cancer stem cells

Developmental Biology

Volumn 430, Issue 2, 2017, Pages 266-274

  O'Brien Ball, Caitlin ^a   Biddle, Adrian ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; Development; EMT; Plasticity; Reprogramming; Stem

Indexed keywords

ADULTHOOD; CANCER STEM CELL; CANCER THERAPY; CELL LINEAGE; CELL METABOLISM; CELL PLASTICITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REPRODUCTION; REVIEW; TISSUE REGENERATION; CYTOLOGY; FORECASTING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; METASTASIS; MUTATION; NEOPLASM; PATHOLOGY; PHENOTYPE;

CELL LINEAGE; CELL PLASTICITY; CELLULAR REPROGRAMMING; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; FORECASTING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; PHENOTYPE;

EID: 85026646437     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2017.07.025     Document Type: Review

References (114)

1. Al-Hajj, M., Clarke, M.F., Self-renewal and solid tumor stem cells. Oncogene 23 (2004), 7274–7282.
2. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F., Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003), 3983–3988.
3. Andriani, F., Bertolini, G., Facchinetti, F., Baldoli, E., Moro, M., Casalini, P., Caserini, R., Milione, M., Leone, G., Pelosi, G., et al. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Mol. Oncol. 10 (2016), 253–271.
4. Asselin-Labat, M.L., Vaillant, F., Sheridan, J.M., Pal, B., Wu, D., Simpson, E.R., Yasuda, H., Smyth, G.K., Martin, T.J., Lindeman, G.J., Visvader, J.E., Control of mammary stem cell function by steroid hormone signalling. Nature 465 (2010), 798–802.
5. Azzam, D.J., Zhao, D., Sun, J., Minn, A.J., Ranganathan, P., Drews-Elger, K., Han, X., Picon-Ruiz, M., Gilbert, C.A., Wander, S.A., et al. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses. EMBO Mol. Med. 5 (2013), 1502–1522.
6. Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Bigner, D.D., Rich, J.N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006), 756–760.
7. Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., Clevers, H., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 (2007), 1003–1007.
8. Battula, V.L., Evans, K.W., Hollier, B.G., Shi, Y., Marini, F.C., Ayyanan, A., Wang, R.Y., Brisken, C., Guerra, R., Andreeff, M., Mani, S.A., Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells 28 (2010), 1435–1445.
9. Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006), 315–326.
10. Biddle, A., Gammon, L., Liang, X., Costea, D.E., Mackenzie, I.C., Phenotypic plasticity determines cancer stem cell therapeutic resistance in oral squamous cell carcinoma. EBioMedicine 4 (2016), 138–145.
11. Biddle, A., Liang, X., Gammon, L., Fazil, B., Harper, L.J., Emich, H., Costea, D.E., Mackenzie, I.C., Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 71 (2011), 5317–5326.
12. Biddle, A., Mackenzie, I.C., Cancer stem cells and EMT in carcinoma. Cancer Metastas. Rev., 2012.
13. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5 (2005), 744–749.
14. Braun, S., Vogl, F.D., Naume, B., Janni, W., Osborne, M.P., Coombes, R.C., Schlimok, G., Diel, I.J., Gerber, B., Gebauer, G., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353 (2005), 793–802.
15. Buczacki, S.J., Zecchini, H.I., Nicholson, A.M., Russell, R., Vermeulen, L., Kemp, R., Winton, D.J., Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 495 (2013), 65–69.
16. Burrell, R.A., McGranahan, N., Bartek, J., Swanton, C., The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501 (2013), 338–345.
17. Cai, S., Kalisky, T., Sahoo, D., Dalerba, P., Feng, W., Lin, Y., Qian, D., Kong, A., Yu, J., Wang, F., et al. A quiescent Bcl11b high stem cell population is required for maintenance of the mammary gland. Cell Stem Cell 20 (2017), 247–260 (e245).
18. Cantone, I., Fisher, A.G., Epigenetic programming and reprogramming during development. Nat. Struct. Mol. Biol. 20 (2013), 282–289.
19. Chaffer, C.L., Brueckmann, I., Scheel, C., Kaestli, A.J., Wiggins, P.A., Rodrigues, L.O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. USA 108 (2011), 7950–7955.
20. Chaffer, C.L., Marjanovic, N.D., Lee, T., Bell, G., Kleer, C.G., Reinhardt, F., D'Alessio, A.C., Young, R.A., Weinberg, R.A., Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154 (2013), 61–74.
21. Cheung, K.J., Gabrielson, E., Werb, Z., Ewald, A.J., Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155 (2013), 1639–1651.
22. Christen, B., Robles, V., Raya, M., Paramonov, I., Izpisúa Belmonte, J.C., Regeneration and reprogramming compared. BMC Biol., 8, 2010, 5.
23. Ciavardelli, D., Rossi, C., Barcaroli, D., Volpe, S., Consalvo, A., Zucchelli, M., De Cola, A., Scavo, E., Carollo, R., D'Agostino, D., et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis., 5, 2014, e1336.
24. Clarke, M.F., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., Visvader, J., Weissman, I.L., Wahl, G.M., Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66 (2006), 9339–9344.
25. Clay, M.R., Tabor, M., Owen, J.H., Carey, T.E., Bradford, C.R., Wolf, G.T., Wicha, M.S., Prince, M.E., Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32 (2010), 1195–1201.
26. Dalerba, P., Cho, R.W., Clarke, M.F., Cancer stem cells: models and concepts. Annu. Rev. Med. 58 (2007), 267–284.
27. Dave, N., Guaita-Esteruelas, S., Gutarra, S., Frias, À., Beltran, M., Peiró S., de Herreros, A.G., Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 286 (2011), 12024–12032.
28. Del Pozo Martin, Y., Park, D., Ramachandran, A., Ombrato, L., Calvo, F., Chakravarty, P., Spencer-Dene, B., Derzsi, S., Hill, C.S., Sahai, E., Malanchi, I., Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization. Cell Rep. 13 (2015), 2456–2469.
29. Easwaran, H., Tsai, H.C., Baylin, S.B., Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 54 (2014), 716–727.
30. Eriksson, D., Stigbrand, T., Radiation-induced cell death mechanisms. Tumour Biol. 31 (2010), 363–372.
31. Festuccia, N., Gonzalez, I., Navarro, P., The epigenetic paradox of pluripotent ES cells. J. Mol. Biol., 2016.
32. Fischer, K.R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S.T., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527 (2015), 472–476.
33. Fisher, R., Pusztai, L., Swanton, C., Cancer heterogeneity: implications for targeted therapeutics. Br. J. Cancer 108 (2013), 479–485.
34. Gammon, L., Biddle, A., Heywood, H.K., Johannessen, A.C., Mackenzie, I.C., Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS One, 8, 2013, e62493.
35. Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C.S., Sahai, E., Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11 (2009), 1287–1296.
36. Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B.T., et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc. Natl. Acad. Sci. USA 107 (2010), 1124–1129.
37. Goldman, A., Majumder, B., Dhawan, A., Ravi, S., Goldman, D., Kohandel, M., Majumder, P.K., Sengupta, S., Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat. Commun., 6, 2015, 6139.
38. Greaves, M., Evolutionary determinants of cancer. Cancer Discov. 5 (2015), 806–820.
39. Green, S.A., Simoes-Costa, M., Bronner, M.E., Evolution of vertebrates as viewed from the crest. Nature 520 (2015), 474–482.
40. Grosse-Wilde, A., Fouquier d'Herouel, A., McIntosh, E., Ertaylan, G., Skupin, A., Kuestner, R.E., del Sol, A., Walters, K.A., Huang, S., Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival. PLoS One, 10, 2015, e0126522.
41. Gupta, P.B., Onder, T.T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R.A., Lander, E.S., Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138 (2009), 645–659.
42. Halleux, C., Sottile, V., Gasser, J.A., Seuwen, K., Multi-lineage potential of human mesenchymal stem cells following clonal expansion. J. Musculoskelet. Neuron. Interact. 2 (2001), 71–76.
43. Hay, E.D., The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233 (2005), 706–720.
44. Heppner, G.H., Tumor heterogeneity. Cancer Res. 44 (1984), 2259–2265.
45. Hermann, P.C., Huber, S.L., Herrler, T., Aicher, A., Ellwart, J.W., Guba, M., Bruns, C.J., Heeschen, C., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1 (2007), 313–323.
46. Huang, R.Y., Wong, M.K., Tan, T.Z., Kuay, K.T., Ng, A.H., Chung, V.Y., Chu, Y.S., Matsumura, N., Lai, H.C., Lee, Y.F., et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis., 4, 2013, e915.
47. Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M., Ellis, E., van Wenum, M., Fuchs, S.A., de Ligt, J., et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 (2015), 299–312.
48. Hudson, L.G., Newkirk, K.M., Chandler, H.L., Choi, C., Fossey, S.L., Parent, A.E., Kusewitt, D.F., Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2). J. Dermatol. Sci. 56 (2009), 19–26.
49. Jensen, D.H., Dabelsteen, E., Specht, L., Fiehn, A.M., Therkildsen, M.H., Jønson, L., Vikesaa, J., Nielsen, F.C., von Buchwald, C., Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. J. Pathol. 236 (2015), 505–516.
50. Jolly, M.K., Boareto, M., Huang, B., Jia, D., Lu, M., Ben-Jacob, E., Onuchic, J.N., Levine, H., Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front. Oncol., 5, 2015, 155.
51. Kalcheim, C., Epithelial-mesenchymal transitions during neural crest and somite development. J. Clin. Med., 2015, 5.
52. Ke, X.S., Qu, Y., Cheng, Y., Li, W.C., Rotter, V., Øyan, A.M., Kalland, K.H., Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genom., 11, 2010, 669.
53. Kelland, L., The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7 (2007), 573–584.
54. Koren, S., Reavie, L., Couto, J.P., De Silva, D., Stadler, M.B., Roloff, T., Britschgi, A., Eichlisberger, T., Kohler, H., Aina, O., et al. PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours. Nature 525 (2015), 114–118.
55. Kreso, A., Dick, J.E., Evolution of the cancer stem cell model. Cell Stem Cell 14 (2014), 275–291.
56. Kreso, A., O'Brien, C.A., van Galen, P., Gan, O.I., Notta, F., Brown, A.M., Ng, K., Ma, J., Wienholds, E., Dunant, C., et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339 (2013), 543–548.
57. Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, T., Penninger, J.M., Jackson, A.P., Knoblich, J.A., Cerebral organoids model human brain development and microcephaly. Nature 501 (2013), 373–379.
58. Lau, A.N., Curtis, S.J., Fillmore, C.M., Rowbotham, S.P., Mohseni, M., Wagner, D.E., Beede, A.M., Montoro, D.T., Sinkevicius, K.W., Walton, Z.E., et al. Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J. 33 (2014), 468–481.
59. Lee, G., Hall, R.R., Ahmed, A.U., Cancer stem cells: cellular plasticity, niche, and its clinical relevance. J. Stem Cell Res. Ther., 2016, 6.
60. Lee, K.M., Lee, M., Lee, J., Kim, S.W., Moon, H.G., Noh, D.Y., Han, W., Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer. Oncotarget 7 (2016), 38500–38512.
61. Lei, J., Levin, S.A., Nie, Q., Mathematical model of adult stem cell regeneration with cross-talk between genetic and epigenetic regulation. Proc. Natl. Acad. Sci. USA 111 (2014), E880–E887.
62. Leopold, P.L., Vincent, J., Wang, H., A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Semin. Cancer Biol. 22 (2012), 471–483.
63. Li, L., Neaves, W.B., Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66 (2006), 4553–4557.
64. Li, X., Lewis, M.T., Huang, J., Gutierrez, C., Osborne, C.K., Wu, M.F., Hilsenbeck, S.G., Pavlick, A., Zhang, X., Chamness, G.C., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100 (2008), 672–679.
65. Lim, J., Thiery, J.P., Epithelial-mesenchymal transitions: insights from development. Development 139 (2012), 3471–3486.
66. Liu, H., Lv, L., Yang, K., Chemotherapy targeting cancer stem cells. Am. J. Cancer Res. 5 (2015), 880–893.
67. Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S.P., Landis, M.D., et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2 (2014), 78–91.
68. Locke, M., Heywood, M., Fawell, S., Mackenzie, I.C., Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 65 (2005), 8944–8950.
69. Lu, D., Choi, M.Y., Yu, J., Castro, J.E., Kipps, T.J., Carson, D.A., Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl. Acad. Sci. USA 108 (2011), 13253–13257.
70. Mahalingam, D., Wilding, G., Denmeade, S., Sarantopoulas, J., Cosgrove, D., Cetnar, J., Azad, N., Bruce, J., Kurman, M., Allgood, V.E., Carducci, M., Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours. Br. J. Cancer 114 (2016), 986–994.
71. Malladi, S., Macalinao, D.G., Jin, X., He, L., Basnet, H., Zou, Y., de Stanchina, E., Massague, J., Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165 (2016), 45–60.
72. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
73. McDonald, O.G., Wu, H., Timp, W., Doi, A., Feinberg, A.P., Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 18 (2011), 867–874.
74. Medema, J.P., Cancer stem cells: the challenges ahead. Nat. Cell Biol. 15 (2013), 338–344.
75. Messerschmidt, D.M., Knowles, B.B., Solter, D., DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos. Genes Dev. 28 (2014), 812–828.
76. Morgani, S.M., Brickman, J.M., The molecular underpinnings of totipotency. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2014, 369.
77. Morrison, S.J., White, P.M., Zock, C., Anderson, D.J., Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 96 (1999), 737–749.
78. Moss, F.P., Leblond, C.P., Nature of dividing nuclei in skeletal muscle of growing rats. J. Cell Biol. 44 (1970), 459–462.
79. Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., Kano, Y., Fukusumi, T., Satoh, T., Takiguchi, S., Mori, M., Doki, Y., Ishii, H., Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26. Oncol. Lett. 9 (2015), 2361–2367.
80. Ocana, O.H., Corcoles, R., Fabra, A., Moreno-Bueno, G., Acloque, H., Vega, S., Barrallo-Gimeno, A., Cano, A., Nieto, M.A., Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22 (2012), 709–724.
81. Ombrato, L., Malanchi, I., The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit. Rev. Oncog. 19 (2014), 349–361.
82. Oshimori, N., Oristian, D., Fuchs, E., TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell 160 (2015), 963–976.
83. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Li, H., Bhatia, B., Tang, S., Reilly, J.G., Chandra, D., Zhou, J., Claypool, K., et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25 (2006), 1696–1708.
84. Pinski, J., Parikh, A., Bova, G.S., Isaacs, J.T., Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts. Cancer Res. 61 (2001), 6372–6376.
85. Piskounova, E., Agathocleous, M., Murphy, M.M., Hu, Z., Huddlestun, S.E., Zhao, Z., Leitch, A.M., Johnson, T.M., DeBerardinis, R.J., Morrison, S.J., Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527 (2015), 186–191.
86. Poncet, C., Frances, V., Gristina, R., Scheiner, C., Pellissier, J.F., Figarella-Branger, D., CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol. 91 (1996), 400–408.
87. Riehle, K.J., Dan, Y.Y., Campbell, J.S., Fausto, N., New concepts in liver regeneration. J. Gastroenterol. Hepatol. 26:Suppl 1 (2011), 203–212.
88. Rios, A.C., Fu, N.Y., Lindeman, G.J., Visvader, J.E., In situ identification of bipotent stem cells in the mammary gland. Nature 506 (2014), 322–327.
89. Roesch, A., Fukunaga-Kalabis, M., Schmidt, E.C., Zabierowski, S.E., Brafford, P.A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., Herlyn, M., A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141 (2010), 583–594.
90. Rumman, M., Dhawan, J., Kassem, M., Concise review: quiescence in adult stem cells: biological significance and relevance to tissue regeneration. Stem Cells 33 (2015), 2903–2912.
91. Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. MYC/PGC-1α balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell Metab. 22 (2015), 590–605.
92. Scaffidi, P., Misteli, T., In vitro generation of human cells with cancer stem cell properties. Nat. Cell Biol. 13 (2011), 1051–1061.
93. Shackleton, M., Vaillant, F., Simpson, K.J., Stingl, J., Smyth, G.K., Asselin-Labat, M.L., Wu, L., Lindeman, G.J., Visvader, J.E., Generation of a functional mammary gland from a single stem cell. Nature 439 (2006), 84–88.
94. Sharma, S., Kelly, T.K., Jones, P.A., Epigenetics in cancer. Carcinogenesis 31 (2010), 27–36.
95. Sharma, S.V., Lee, D.Y., Li, B., Quinlan, M.P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M.A., et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141 (2010), 69–80.
96. Shenoy, A., Blelloch, R.H., Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat. Rev. Mol. Cell Biol. 15 (2014), 565–576.
97. Sottoriva, A., Kang, H., Ma, Z., Graham, T.A., Salomon, M.P., Zhao, J., Marjoram, P., Siegmund, K., Press, M.F., Shibata, D., Curtis, C., A Big Bang model of human colorectal tumor growth. Nat. Genet. 47 (2015), 209–216.
98. Stingl, J., Detection and analysis of mammary gland stem cells. J. Pathol. 217 (2009), 229–241.
99. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
100. Tam, W.L., Weinberg, R.A., The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 19 (2013), 1438–1449.
101. Teperek, M., Simeone, A., Gaggioli, V., Miyamoto, K., Allen, G.E., Erkek, S., Kwon, T., Marcotte, E.M., Zegerman, P., Bradshaw, C.R., et al. Sperm is epigenetically programmed to regulate gene transcription in embryos. Genome Res. 26 (2016), 1034–1046.
102. Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002), 442–454.
103. Thiery, J.P., Sleeman, J.P., Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7 (2006), 131–142.
104. Tsai, J.H., Donaher, J.L., Murphy, D.A., Chau, S., Yang, J., Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22 (2012), 725–736.
105. Viale, A., Pettazzoni, P., Lyssiotis, C.A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514 (2014), 628–632.
106. Vig, N., Mackenzie, I.C., Biddle, A., Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma. J. Oral. Pathol. Med. 44 (2015), 649–655.
107. Visvader, J.E., Stingl, J., Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 28 (2014), 1143–1158.
108. Waddington, C.H., The Strategy of the Genes. A Discussion with Some Aspects of Theoretical Biologys. 1957, George Allen&Unwin, Ltd., London.
109. Wheelock, M.J., Shintani, Y., Maeda, M., Fukumoto, Y., Johnson, K.R., Cadherin switching. J. Cell Sci. 121 (2008), 727–735.
110. Williams, M.J., Werner, B., Barnes, C.P., Graham, T.A., Sottoriva, A., Identification of neutral tumor evolution across cancer types. Nat. Genet. 48 (2016), 238–244.
111. Xu, J., Lamouille, S., Derynck, R., TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19 (2009), 156–172.
112. Yang, M.H., Wu, M.Z., Chiou, S.H., Chen, P.M., Chang, S.Y., Liu, C.J., Teng, S.C., Wu, K.J., Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat. Cell Biol. 10 (2008), 295–305.
113. Yeung, T.M., Gandhi, S.C., Wilding, J.L., Muschel, R., Bodmer, W.F., Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl. Acad. Sci. USA 107 (2010), 3722–3727.
114. Zheng, X., Carstens, J.L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.C., LeBleu, V.S., Kalluri, R., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527 (2015), 525–530.